Effectiveness of UNAIDS targets and HIV vaccination across 127 countries

Alison P. Galvani; Amber Tang; Jan Medlock; Alyssa S. Parpia; Abhishek Pandey; Laura A. Skrip

Citeable URL: http://ir.library.oregonstate.edu/concern/articles/rb68xh59m

Descriptions

Attribute Name	Values
Creator	Alison P. Galvani Amber Tang Jan Medlock Alyssa S. Parpia Abhishek Pandey Laura A. Skrip
Abstract or Summary	The HIV pandemic continues to impose enormous morbidity, mortality and economic burdens across the globe. Simultaneously, innovations in antiretroviral therapy, diagnostic approaches and vaccine development are providing novel tools for treatment-as-prevention and prophylaxis. We developed a mathematical model to evaluate the added benefit of an HIV vaccine in the context of goals to increase rates of diagnosis, treatment, and viral suppression in 127 countries. Under status quo interventions, we predict a median of 49 million [1st and 3rd quartiles 44M, 58M] incident cases globally from 2015 to 2035. Achieving the UNAIDS 95–95–95 target was estimated to avert 25 million [20M, 33M] of these new infections, and an additional 6.3 million [4.8M, 8.7M] reduction was projected with the 2020 introduction of a 50%-efficacy vaccine gradually scaled up to 70% coverage. This added benefit of prevention through vaccination motivates imminent and ongoing clinical trials of viable candidates to realize the goal of HIV control.
Resource Type	Article
Date Available	2017-03-20T20:47:58+00:00
Date Issued	2017-03-20
Rights Statement	Copyright Not Evaluated
Funding Statement (additional comments about funding)	J.M. was supported by National Institutes of Health U01 GM070694. A.P. was supported by a Brown CoxePostdoctoral Fellowship in the Medical Sciences. A.S.P. and A.P.G. were supported by National Institutes of Health U01 GM15627 and National Institutes of Health U01 GM087719. A.T. was supported by a Yale College Dean’s Research Fellowship. L.A.S. was supported by National Institutes of Health T32 AI007404.5
Peer Reviewed	Yes
Replaces	http://hdl.handle.net/1957/60548
Additional Information	description.provenance : Submitted by Open Access (openaccess@library.oregonstate.edu) on 2017-03-15T18:00:06Z No. of bitstreams: 2 Effectiveness_of_HIV_vaccine_final.pdf: 961418 bytes, checksum: ad36c1eecba0c9dc426016a94380f928 (MD5) supporting_information.pdf: 11817801 bytes, checksum: 7a4b51bb6caf0b6c4e9f56d802bc18e7 (MD5) description.provenance : Made available in DSpace on 2017-03-20T20:47:58Z (GMT). No. of bitstreams: 3 medlockj2051261764.zip: 12301076 bytes, checksum: 08f28daed51216c7181c7d5a42d344bf (MD5) Effectiveness_of_HIV_vaccine_final.pdf: 961418 bytes, checksum: ad36c1eecba0c9dc426016a94380f928 (MD5) supporting_information.pdf: 11817801 bytes, checksum: 7a4b51bb6caf0b6c4e9f56d802bc18e7 (MD5) description.provenance : Approved for entry into archive by Steven Van Tuyl(steve.vantuyl@oregonstate.edu) on 2017-03-20T20:47:58Z (GMT) No. of bitstreams: 3 medlockj2051261764.zip: 12301076 bytes, checksum: 08f28daed51216c7181c7d5a42d344bf (MD5) Effectiveness_of_HIV_vaccine_final.pdf: 961418 bytes, checksum: ad36c1eecba0c9dc426016a94380f928 (MD5) supporting_information.pdf: 11817801 bytes, checksum: 7a4b51bb6caf0b6c4e9f56d802bc18e7 (MD5)

Relationships

Parents:: This work has no parents.

Thumbnail	Title	Date Uploaded	Visibility	Actions
	Effectiveness_of_HIV_vaccine_final.pdf	11/16/2017	Public
	supporting_information.pdf	11/16/2017	Public

ScholarsArchive@OSU

Effectiveness of UNAIDS targets and HIV vaccination across 127 countries Public Deposited

Descriptions

Relationships

Items